Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  1996-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD000087PMID 10796690PMCID PMC10866112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis.

  1995cited by this paper
• Exogenous Gonadotropin Therapy in World Health Organization Groups I and II Ovulatory Disorders

  1994cited by this paper
• Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.

  1993cited by this paper
• Endocrine changes and follicular development in patients during ovulation induction using Goserelin and different gonadotropin treatments.

  1993cited by this paper
• Comparison of urinary human follicle‐stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome

  1991cited by this paper
• Treatment of clomiphene citrate‐resistant polycystic ovarian syndrome with pure follicle‐stimulating hormone or human menopausal gonadotropin

  1991cited by this paper
• A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome.

  1991cited by this paper
• Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome *

  1990cited by this paper
• Hypersecretion of luteinising hormone, infertility, and miscarriage.

  1990cited by this paper
• OVARIAN ELECTROCAUTERY VERSUS HUMAN MENOPAUSAL GONADOTROPHINS AND PURE FOLLICLE STIMULATING HORMONE THERAPY IN THE TREATMENT OF PATIENTS WITH POLYCYSTIC OVARIAN DISEASE

  1990cited by this paper
• Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.

  1990cited by this paper
• A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome.

  1989cited by this paper
• Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.

  1988cited by this paper
• Recurrent early miscarriage and polycystic ovaries.

  1988cited by this paper
• Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency.

  1988cited by this paper
• Stimulation of Ovarian Follicular Maturation With Pure Follicle-Stimulating Hormone in Women with Gonadotropin Deficiency

  1988cited by this paper
• Why do we need systematic overviews of randomized trials?

  1987cited by this paper
• Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin.

  1985cited by this paper
• FACTORS INFLUENCING THE PREGNANCY AND COMPLICATION RATES WITH HUMAN MENOPAUSAL GONADOTROPHIN THERAPY

  1975cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Physiologic and Pathophysiologic Alterations of the Neuroendocrine Components of the Reproductive Axis

  2019cites this paper
• The ultrasonographic detection of follicular rupture at the time of intrauterine insemination: is it really decisive?

  2015cites this paper
• WITHDRAWN: Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.

  2015cites this paper
• Gonadotrophins for Ovulation Induction

  2014cites this paper
• Sequential clomiphene citrate/hMG versus hMG for ovulation induction in clomiphene citrate-resistant women

  2012influential citation
• Contemporary Pharmacological Manipulation in Assisted Reproduction

  2012cites this paper
• Difficult-to-treat women for controlled ovarian hyperstimulation: tips and tricks

  2011cites this paper
• New insights in prediction of ovarian hyperstimulation syndrome.

  2011cites this paper
• Clinical Outcomes of Ovulation Induction with Metformin, Clomiphene Citrate and Human Menopausal Gonadotrophin in Polycystic Ovary Syndrome

  2010cites this paper
• Ovulation Induction in Anovulatory Patients with Polycystic Ovary Syndrome

  2010cites this paper
• Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome

  2010cites this paper
• Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance

  2009cites this paper
• The Effect of PCOS on Fertility and Pregnancy

  2009cites this paper
• IVF in Polycystic Ovary Syndrome

  2009cites this paper
• A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization.

  2008cites this paper
• Polycystic ovary syndrome

  2007cites this paper
• Searching for the optimal GnRH antagonist regimen to compare with GnRH agonists in IVF

  2007cites this paper
• Infertility in polycystic ovary syndrome

  2006cites this paper
• LH in the follicular phase: neither too high nor too low.

  2006cites this paper
• A twenty-first century research agenda for polycystic ovary syndrome.

  2006cites this paper
• Ovulation induction with clomiphene or gonadotropins

  2005cites this paper
• The role of luteinizing hormone activity in controlled ovarian stimulation

  2005cites this paper
• Hormonelle Therapie des polyzystischen Ovarsyndroms (PLOS)

  2005cites this paper
• Recurrent miscarriage

  2005cites this paper
• Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization.

  2005cites this paper
• Management of Infertility in Women with Polycystic Ovary Syndrome

  2005cites this paper
• Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?

  2004cites this paper
• Pregnancy following monofollicular ovulation induction with recombinant FSH, recombinant LH and timed coitus in an amenorrheic woman with long‐standing hypogonadotrophic hypogonadism

  2004cites this paper
• Current concepts and novel applications of LH activity in ovarian stimulation.

  2003cites this paper
• Polycystic ovary syndrome and ovulation induction.

  2003cites this paper
• Assessment and management of anovulatory infertility in polycystic ovary syndrome.

  2003cites this paper
• GnRH antagonists in normal- responder patients.

  2003cites this paper
• A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome.

  2003cites this paper
• Ovulation induction

  2003cites this paper
• Ovarian hyperstimulation syndrome: distinction between local and systemic disease

  2003cites this paper
• Optimizing ovulation induction in women with polycystic ovary syndrome

  2002cites this paper
• Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.

  2002cites this paper
• A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins.

  2001cites this paper
• Polycystic ovary syndrome: the new millenium

  2001cites this paper
• Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.

  2001cites this paper
• A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women

  1998cites this paper
• A Prospective, Open, Randomized Clinical Study to Assess the Efficacy and Safety of Two Gonadotropin Preparations Administered in WHO Group II Anovulatory Subfertile Women

  1998cites this paper